NEW
YORK, Feb. 1, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law
firm, is investigating potential claims related to the below-listed
proposed mergers. Kuehn Law may seek
additional disclosures or other relief on behalf of the
shareholders of these companies.
Kuehn Law is investigating
whether the Boards of the below companies 1) acted to maximize
shareholder value, 2) failed to disclose material information, and
3) conducted a fair process:
- Icosavax, Inc. (Nasdaq: ICVX) click to participate
According to the agreement terms, AstraZeneca will, via a
subsidiary, start a tender offer to purchase all outstanding shares
of Icosavax for $15.00 per share in
cash. Additionally, shareholders will receive a non-tradable
contingent value right for up to $5.00 in cash.
- CapStar Financial Holdings, Inc. (Nasdaq: CSTR) click to
participate
CapStar Financial Holdings has agreed to merge with Old National
Bancorp. Under the proposed transaction CapStar shareholders will
receive 1.155 shares of Old National common stock per share.
- AVROBIO, Inc. (Nasdaq: AVRO) click to participate
AVROBIO has agreed to merge with Tectonic Therapeutic. Under the
agreement, current shareholders of AVROBIO are anticipated to hold
about 22.3% of the merged entity.
- California BanCorp (Nasdaq: CALB) click to
participate
Southern California Bancorp has agreed to acquire California
BanCorp. Under the terms of the agreement, for every share of
California BanCorp common stock held, shareholders will receive
1.590 shares of Southern California Bancorp common stock. Following
the merger, California BanCorp's investors will hold around 42.9%
of the new entity.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved,
you contribute to the integrity and fairness of the financial
markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to
safeguarding shareholder interests. Concerned shareholders are
encouraged to contact Justin Kuehn,
Esq., at justin@kuehn.law or call (833) 672-0814.
Kuehn Law covers all case costs
and does not charge its investor clients. Shareholders
are advised to act promptly, as legal rights may be
time-sensitive. For additional information, please visit Merger
Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar
outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-icvx-cstr-avro-and-calb-investors-to-contact-law-firm-302051209.html
SOURCE Kuehn Law, PLLC